Journals Library Health Technology Assessment CRASH-2: a trial of tranexamic acid in serious injury Given within three hours of injury, tranexamic acid reduces deaths in people who are bleeding heavily

First Page		Document Content
Date: 2014-01-20 10:28:45 Antifibrinolytics Tranexamic acid Coagulation system Fibrinolysis Placebo Stroke Coagulation Hereditary angioedema Lysergic acid diethylamide Blood Medicine Anatomy		Journals Library Health Technology Assessment CRASH-2: a trial of tranexamic acid in serious injury Given within three hours of injury, tranexamic acid reduces deaths in people who are bleeding heavily Add to Reading List Source URL: www.nets.nihr.ac.uk Download Document from Source Website File Size: 125,05 KB Share Document on Facebook

	Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave. DocID: 1riKA - View Document
	Microsoft Wordfile00 DocID: 1r9dZ - View Document
	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites DocID: 1qHpD - View Document
	RECOTHROM, Thrombin topical (Recombinant) Package Insert DocID: 1qv5K - View Document
	Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve DocID: 1qk7W - View Document